Christina Misidou

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Multiple Myeloma

Randomized Controlled Trial

Palliative Care

Top Venues

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Konstantinos Liapis, Christina Misidou, Emmanouil Spanoudakis, Ioannis Kotsianidis
Concurrent visceral leishmaniasis and diffuse large B-cell lymphoma of the bone marrow. British journal of haematology 204 (4) (2024)
Konstantinos Liapis, Christina Misidou, Emmanouil Spanoudakis, Ioannis Kotsianidis
Concurrent visceral leishmaniasis and diffuse large B-cell lymphoma of the bone marrow. British journal of haematology (2024)
Konstantinos Liapis, Christina Misidou, Emmanouil Spanoudakis, Ioannis Kotsianidis
Concurrent visceral leishmaniasis and diffuse large B-cell lymphoma of the bone marrow. British journal of haematology 204 (4) (2024)
Ioannis Petrakis, Christos A Kontogiorgis, Evangelia Nena, Sosana Delimpasi, Natasa E Loutsidi, Emmanouil Spanoudakis, Stergios Intzes, Christina Misidou, Marianthi Symeonidou, Nikolaos Giannakoulas, Theodoros C Constantinidis, Evangelos Terpos
Does the Simultaneous Introduction of Several Pharmaceuticals in the Post-Lenalidomide Era Translate to Better Outcomes in Relapse Refractory Multiple Myeloma? Findings from the Real-World Innovation in Multiple Myeloma (REAL IMM) Study. Cancers 15 (24) (2023)
Ioannis Petrakis, Christos A Kontogiorgis, Evangelia Nena, Sosana Delimpasi, Natasa E Loutsidi, Emmanouil Spanoudakis, Stergios Intzes, Christina Misidou, Marianthi Symeonidou, Nikolaos Giannakoulas, Theodoros C Constantinidis, Evangelos Terpos
Does the Simultaneous Introduction of Several Pharmaceuticals in the Post-Lenalidomide Era Translate to Better Outcomes in Relapse Refractory Multiple Myeloma? Findings from the Real-World Innovation in Multiple Myeloma (REAL IMM) Study. Cancers 15 (24) (2023)